SEI Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-28,932
Closed -$2.95M 2516
2019
Q3
$2.95M Sell
28,932
-215
-0.7% -$20.4K 0.01% 1162
2019
Q2
$2.74M Sell
29,147
-409
-1% -$38.8K 0.01% 1189
2019
Q1
$2.83M Sell
29,556
-121,749
-80% -$10.6M 0.01% 1166
2018
Q4
$12.7M Buy
151,305
+16,811
+12% +$1.24M 0.05% 447
2018
Q3
$12.1M Sell
134,494
-5,088
-4% -$450K 0.04% 447
2018
Q2
$11.1M Sell
139,582
-87,883
-39% -$7.3M 0.04% 523
2018
Q1
$20.3M Sell
227,465
-324,831
-59% -$31.2M 0.08% 269
2017
Q4
$57.6M Sell
552,296
-318,874
-37% -$36M 0.2% 95
2017
Q3
$127M Buy
871,170
+1,152
+0.1% +$157K 0.45% 32
2017
Q2
$113M Buy
870,018
+31,325
+4% +$3.84M 0.45% 33
2017
Q1
$104M Sell
838,693
-5,490
-0.7% -$657K 0.46% 29
2016
Q4
$97.7M Buy
844,183
+18,293
+2% +$2.04M 0.47% 25
2016
Q3
$86.3M Sell
825,890
-64,486
-7% -$6.98M 0.44% 30
2016
Q2
$87.8M Buy
890,376
+33,059
+4% +$3.42M 0.53% 18
2016
Q1
$85.8M Sell
857,317
-95,783
-10% -$9.86M 0.53% 17
2015
Q4
$114M Buy
953,100
+327,275
+52% +$37.9M 0.7% 16
2015
Q3
$67.7M Buy
625,825
+26,805
+4% +$3.33M 0.62% 19
2015
Q2
$69.3M Buy
599,020
+17,799
+3% +$2.03M 0.63% 19
2015
Q1
$67M Sell
581,221
-67,606
-10% -$8.08M 0.58% 22
2014
Q4
$72.6M Buy
+648,827
New +$68.4M 0.64% 19

Other funds holding CELG

SEI Investments's CELG Position: Q4 2019 in Review

SEI Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 28,932 shares — an estimated $2.95M sold.

SEI Investments first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $127M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SEI Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SEI Investments sold 28,932 Celgene Corp shares in Q4 2019, an estimated $2.95M.
  • SEI Investments first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • SEI Investments's Celgene Corp position peaked at $127M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SEI Investments's 13F filing for Q4 2019, filed 6 Feb 2020.